Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 2.139E-07 | 1.664E-04 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0009987; cellular process | GO:0043401; steroid hormone mediated signaling pathway | 3.067E-07 | 2.303E-04 | ESR2, NR1H4, PPARA, PPARD, PPARG, RORC |
BP | GO:0008152; metabolic process | GO:0006367; transcription initiation from RNA polymerase II promoter | 1.040E-06 | 7.079E-04 | ESR2, NR1H4, PPARA, PPARD, PPARG, RORC |
BP | GO:0009987; cellular process | GO:0030522; intracellular receptor signaling pathway | 1.754E-06 | 1.061E-03 | ESR2, NR1H4, PPARA, PPARD, PPARG, RORC |
BP | GO:0065007; biological regulation | GO:0055088; lipid homeostasis | 3.478E-06 | 1.942E-03 | FABP3, FABP4, NPC1, NR1H4, PPARG |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 4.328E-06 | 2.207E-03 | NR1H4, PPARA, PPARD, PPARG, PTPN2 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 1.215E-05 | 4.812E-03 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.272E-05 | 4.860E-03 | AKR1B10, CYP1A2, HSD11B1, NPC1, NR1H4, PPARD |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.317E-05 | 4.860E-03 | CA2, CA7 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 1.317E-05 | 4.860E-03 | GPBAR1, NR1H4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 7.579E-27 | 5.760E-25 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA4; CA7; CA6; CA9; CA14 |
hsa03320 | PPAR signaling pathway_Homo sapiens_hsa03320 | 8.717E-11 | 3.312E-09 | FABP2; FABP3; FABP4; FABP5; PPARG; PPARA; PPARD |
hsa04520 | Adherens junction_Homo sapiens_hsa04520 | 4.685E-04 | 8.902E-03 | PTPN1; ACP1; PTPRF |
hsa04931 | Insulin resistance_Homo sapiens_hsa04931 | 1.444E-03 | 1.829E-02 | PTPN1; PPARA; PTPRF |
hsa04964 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.009E-03 | 1.534E-02 | CA2; CA4 |
hsa05134 | Legionellosis_Homo sapiens_hsa05134 | 1.948E-04 | 4.935E-03 | CASP7; CASP1; TLR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Infections | A00-B99 | PTPN1 |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A |
C00-D49: Neoplasms | Melanoma | C43 | TERT; TLR2 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9; TLR2 |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | FAAH |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Liver cancer | C22 | TERT |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TERT |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; TLR2 |
C00-D49: Neoplasms | Multiple myeloma | C90 | TERT |